Please login to the form below

Not currently logged in
Email:
Password:

Digital guidance for pharma

Pharmaceutical industry associations and regulators are gradually producing guidelines for companies on the use of digital and social media channels.

Pharmaceutical industry associations and regulators are gradually producing guidelines for companies on the use of digital and social media channels.

Swedish pharma association LIF has an 'interpretative document' on social media and the ethical rules for companies.

The document gives some examples of social media situations to help companies evaluate when the use of these media is appropriate with regards to Swedish pharma's ethical rules (LER).

Members of Turkish pharma association AIFD have produced a guide on digital communication and digital marketing practices.

It provides guidance on corporate websites, websites for patients and the general public, websites for healthcare professionals, web-based promotional methods, social media and electronic information sharing.

In the UK the PMCPA, which regulates the ABPI's Code of Practice, has guidance on the use of social media and other digital communications tools.

The PMCPA produced a Q&A document to explain how digital communication tools fit into its existing regulations. Meanwhile, the ABPI itself has guidance on managing adverse events from pharma-sponsored websites.

In the US the FDA has issued draft guidance about how pharma can respond to unsolicited requests for information about off-label use. Such requests include those that come from “emerging electronic media”, a term that covers a range of online channels including social media.

3rd April 2012

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Infographics